Shoba Amarnath

6.4k total citations
37 papers, 1.5k citations indexed

About

Shoba Amarnath is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Shoba Amarnath has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 10 papers in Oncology and 7 papers in Surgery. Recurrent topics in Shoba Amarnath's work include Immune Cell Function and Interaction (25 papers), T-cell and B-cell Immunology (19 papers) and Immunotherapy and Immune Responses (12 papers). Shoba Amarnath is often cited by papers focused on Immune Cell Function and Interaction (25 papers), T-cell and B-cell Immunology (19 papers) and Immunotherapy and Immune Responses (12 papers). Shoba Amarnath collaborates with scholars based in United States, United Kingdom and Italy. Shoba Amarnath's co-authors include Daniel H. Fowler, Jason Foley, Tania C. Felizardo, Veena Kapoor, Arian Laurence, Jacopo Mariotti, Carl H. June, Bruce L. Levine, Grace Mallett and James L. Riley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Shoba Amarnath

35 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoba Amarnath United States 17 996 493 316 198 128 37 1.5k
Elizabeth C. Nowak United States 17 1.4k 1.4× 635 1.3× 242 0.8× 112 0.6× 77 0.6× 26 1.9k
Hanke L. Matlung Netherlands 21 1.1k 1.1× 387 0.8× 611 1.9× 115 0.6× 99 0.8× 37 1.8k
Debra Zack United States 24 567 0.6× 349 0.7× 561 1.8× 119 0.6× 212 1.7× 35 1.7k
Minh Diem Vu United States 17 848 0.9× 295 0.6× 261 0.8× 238 1.2× 100 0.8× 26 1.4k
Sylvain Perruche France 23 1.4k 1.4× 227 0.5× 444 1.4× 149 0.8× 266 2.1× 55 1.9k
Jens Volkmer United States 8 862 0.9× 355 0.7× 381 1.2× 79 0.4× 162 1.3× 9 1.4k
Amy E. Lin United States 18 501 0.5× 304 0.6× 453 1.4× 84 0.4× 162 1.3× 32 1.3k
Tobias A.W. Holderried Germany 19 1.2k 1.2× 549 1.1× 629 2.0× 143 0.7× 133 1.0× 58 1.9k
Christoph Bergmann Germany 22 1.6k 1.6× 953 1.9× 411 1.3× 165 0.8× 69 0.5× 54 2.3k
Francesca Wanda Rossi Italy 25 779 0.8× 256 0.5× 446 1.4× 182 0.9× 119 0.9× 82 1.8k

Countries citing papers authored by Shoba Amarnath

Since Specialization
Citations

This map shows the geographic impact of Shoba Amarnath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoba Amarnath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoba Amarnath more than expected).

Fields of papers citing papers by Shoba Amarnath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoba Amarnath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoba Amarnath. The network helps show where Shoba Amarnath may publish in the future.

Co-authorship network of co-authors of Shoba Amarnath

This figure shows the co-authorship network connecting the top 25 collaborators of Shoba Amarnath. A scholar is included among the top collaborators of Shoba Amarnath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoba Amarnath. Shoba Amarnath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McDonald, David, Gillian Hulme, Rafiqul Hussain, et al.. (2025). Deciphering Novel Communication Patterns in T Regulatory Cells From Very Old Adults. Aging Cell. 24(7). e70044–e70044. 1 indexed citations
2.
Singla, Pankaj, Thomas Broughton, Mark V. Sullivan, et al.. (2024). Double Imprinted Nanoparticles for Sequential Membrane‐to‐Nuclear Drug Delivery. Advanced Science. 11(36). e2309976–e2309976. 13 indexed citations
3.
McDonald, David, Gillian Hulme, Rafiqul Hussain, et al.. (2024). Deep phenotyping of T regulatory cells in psoriatic arthritis highlights targetable mechanisms of disease. Journal of Biological Chemistry. 301(1). 108059–108059. 6 indexed citations
4.
Mann, Derek A., et al.. (2024). A silver bullet for ageing medicine?: clinical relevance of T-cell checkpoint receptors in normal human ageing. Frontiers in Immunology. 15. 1360141–1360141. 1 indexed citations
5.
Sciumè, Giuseppe, et al.. (2023). Twenty-One Flavors of Type 1 Innate Lymphoid Cells with PD-1 (Programmed Cell Death-1 Receptor) Sprinkles. PubMed. 2(1). kyad003–kyad003. 1 indexed citations
6.
Mallett, Grace, et al.. (2020). Isolation and Characterization of Innate Lymphoid Cells within the Murine Tumor Microenvironment. Methods in molecular biology. 2121. 153–164. 1 indexed citations
7.
Amarnath, Shoba, et al.. (2020). Harnessing proteases for T regulatory cell immunotherapy. European Journal of Immunology. 50(6). 770–778. 6 indexed citations
8.
Amarnath, Shoba. (2020). Protocols for Innate Lymphoid Cell Phenotypic and Functional Characterization: An Overview. Methods in molecular biology. 2121. 1–6.
9.
Amarnath, Shoba, et al.. (2016). Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and Leukemia. Molecular Therapy. 24(9). 1655–1664. 9 indexed citations
10.
Mitra, Suman, Aaron M. Ring, Shoba Amarnath, et al.. (2015). Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps. Immunity. 42(5). 826–838. 126 indexed citations
11.
Massey, Paul R., et al.. (2013). Rapamycin Resistant Murine Th9 Cells Have a Stable In Vivo Phenotype and Inhibit Graft-Versus-Host Reactivity. PLoS ONE. 8(8). e72305–e72305. 9 indexed citations
12.
Felizardo, Tania C., Jason Foley, Boro Dropulić, et al.. (2013). Harnessing autophagy for cell fate control gene therapy. Autophagy. 9(7). 1069–1079. 7 indexed citations
13.
Vázquez, Nancy, et al.. (2012). Modulation of Innate Host Factors by Mycobacterium avium Complex in Human Macrophages Includes Interleukin 17. The Journal of Infectious Diseases. 206(8). 1206–1217. 9 indexed citations
14.
Amarnath, Shoba, Jason Foley, Carliann M. Costanzo, et al.. (2011). Host-Based Th2 Cell Therapy for Prolongation of Cardiac Allograft Viability. PLoS ONE. 6(4). e18885–e18885. 7 indexed citations
15.
Amarnath, Shoba, Francis A. Flomerfelt, Carliann M. Costanzo, et al.. (2010). Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD. Autophagy. 6(4). 523–541. 27 indexed citations
16.
Amarnath, Shoba, Carliann M. Costanzo, Jacopo Mariotti, et al.. (2010). Regulatory T Cells and Human Myeloid Dendritic Cells Promote Tolerance via Programmed Death Ligand-1. PLoS Biology. 8(2). e1000302–e1000302. 79 indexed citations
17.
Mariotti, Jacopo, Justin J. Taylor, Paul R. Massey, et al.. (2010). The Pentostatin Plus Cyclophosphamide Nonmyeloablative Regimen Induces Durable Host T Cell Functional Deficits and Prevents Murine Marrow Allograft Rejection. Biology of Blood and Marrow Transplantation. 17(5). 620–631. 14 indexed citations
18.
Amarnath, Shoba, Dong Li, Jun Li, Yuntao Wu, & Wanjun Chen. (2007). Endogenous TGF-β activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25-T cells. Retrovirology. 4(1). 57–57. 72 indexed citations
19.
Liu, Yongzhong, Shoba Amarnath, & WanJun Chen. (2006). Requirement of CD28 Signaling in Homeostasis/Survival of TGF-β Converted CD4+CD25+ Tregs from Thymic CD4+CD25− Single Positive T Cells. Transplantation. 82(7). 953–964. 25 indexed citations
20.
Amarnath, Shoba, et al.. (2004). In vitro quantification of the cytotoxic T lymphocyte response against human telomerase reverse transcriptase in breast cancer. International Journal of Oncology. 25(1). 211–7. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth C. Nowak Breakdown of academic impact, for papers by Hanke L. Matlung Breakdown of academic impact, for papers by Debra Zack Breakdown of academic impact, for papers by Minh Diem Vu Breakdown of academic impact, for papers by Sylvain Perruche Breakdown of academic impact, for papers by Jens Volkmer Breakdown of academic impact, for papers by Amy E. Lin Breakdown of academic impact, for papers by Tobias A.W. Holderried Breakdown of academic impact, for papers by Christoph Bergmann Breakdown of academic impact, for papers by Francesca Wanda Rossi
Rankless by CCL
2026